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Introduction {#sec1}
============

Pluripotent stem cells (PSCs) are characterized by continuous self-renewal while maintaining the potential to differentiate into cells of all three germ layers. Great knowledge exists about the regulatory networks that maintain pluripotency and about key players that regulate differentiation. Pluripotency exists in various states, with the ground state of naive pluripotency as the most basic state of pluripotency ([@bib10], [@bib38], [@bib66]). Here, diverse signaling pathways, in concert with a combination of key transcription factors (TFs), precisely regulate ground state conditions. Diminutive changes in their expression can either destabilize or strengthen the network ([@bib31]). Several network TFs are heterogeneously expressed ([@bib9], [@bib19], [@bib29], [@bib41], [@bib44], [@bib50]) and regulated in a highly dynamic manner to balance between stem cell self-renewal and exit from pluripotency ([@bib18], [@bib53]) as well as during somatic reprogramming ([@bib59]). Finally, even core TFs of the pluripotency network determine the exit from stemness to early cell fate determination in a competitive manner ([@bib40], [@bib60], [@bib63], [@bib64]).

The T-box family of TFs is involved in a variety of signaling cascades including the pluripotency network ([@bib48]). TBX3 mutually regulates the expression of key lineage TFs factors while maintaining and inducing pluripotency ([@bib24], [@bib64]). In detail, TBX3 is directly bound by NANOG and in turn binds OCT4 and SOX2 ([@bib24]). Its expression is regulated in part by the phosphatidylinositol-3-OH-kinase-Akt (PI3K) and mitogen-activated protein kinase (MAPK) pathways ([@bib48]). Moreover, TBX3 can bypass the requirement for leukemia inhibitory factor (LIF) signaling and functions upstream of NANOG in PSCs ([@bib48]). Removal of TBX3 from embryonic stem cells (ESCs) causes differentiation ([@bib24], [@bib28], [@bib37], [@bib40], [@bib47]). In contrast, TBX3 is also a crucial player in early cell fate events, driving mesendodermal and primitive endoderm (PE) specification ([@bib30], [@bib40], [@bib63], [@bib64]). Here, we provide a comprehensive view on the definitive requirements for TBX3 to maintain and induce pluripotency and precisely characterize various TBX3-expression states in PSCs.

Results {#sec2}
=======

TBX3 Is Dynamically Expressed in mESCs {#sec2.1}
--------------------------------------

Heterogeneous expression of pluripotency TFs is present under various culture conditions, to date focused on the TF Nanog ([@bib14], [@bib67]). Heterogeneous *Tbx3* expression has been reported in mouse ESCs (mESCs) ([@bib48], [@bib62]). The relevance of such heterogeneity in vitro remains divisive in vivo. To access TBX3 expression in vivo, we used a mouse strain containing a Venus-cassette (ven) to disrupt and track endogenous TBX3 locus activity ([@bib35]). We observed a heterogeneous venus signal tracking TBX3 protein in both morula and blastocyst stages of murine embryos ([Figure 1](#fig1){ref-type="fig"}A). Immunohistochemistry (IHC) of wild-type embryos confirmed this observation, where NANOG-positive epiblast (EPI) cells express varying levels of TBX3 ([Figure 1](#fig1){ref-type="fig"}B). Interestingly, the inner cell mass (ICM) cells with high TBX3 expression tend to have increased PDGFRA and decreased NANOG expression, suggestive of a PE cell fate. In contrast, low TBX3 expression correlates with high NANOG expression, indicative of an EPI fate.

For a global overview on *Tbx3* expression in vivo at early developmental stages, we performed in silico analyses of published datasets investigating single-cell transcriptomes of morula and blastocyst stages ([@bib7], [@bib13], [@bib52]). Violin plots depict a bimodal expression of *Nanog* and *Tbx3*, whereas *Oct4* expression recapitulates a described increase of transcriptional noise with ongoing development ([@bib52]) and separates just upon ICM and trophectoderm (TE) segregation ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1D). Next, we applied a defined gene signature of 48 TFs capable to segregate the three lineages in pre-implantation embryos, namely PE, EPI, both defining the ICM, and TE ([@bib23]). This gene signature separates two cell populations as early as in the 16-cell stage, which could be allocated to the later putative ICM and TE ([Figure S1](#mmc1){ref-type="supplementary-material"}E). This separation becomes more evident with ongoing development and maximizes in the late blastocyst ([Figures S1](#mmc1){ref-type="supplementary-material"}F and S1G). All clustered samples indicate heterogeneous single-embryonic-cell *Tbx3* expression in vivo across both lineages (ICM and TE). Moreover, *Tbx3* closely clusters with distinct TFs in the three embryonic stages regulating different lineages, supporting its role for lineage segregation ([Figures S1](#mmc1){ref-type="supplementary-material"}E--S1G). We used this single-cell-based transcriptional lineage segregation to illustrate heterogeneous *Tbx3* expression ([Figures S1](#mmc1){ref-type="supplementary-material"}H--S1J). Box plots illustrate the greater heterogeneity of *Tbx3* compared to *Oct4* in the ICM, most evident in the early blastocyst ([Figure S1](#mmc1){ref-type="supplementary-material"}I). Finally, for each gene in the signature, we calculated Pearson correlation for *Tbx3* using all single embryonic cells at the late blastocyst stage to identify genes being positively or negatively correlated with *Tbx3* ([Figure S1](#mmc1){ref-type="supplementary-material"}K). We note that TBX3-high in vivo may bias toward PE (high correlation with *Pdgfra*), thus recapitulating our immunostainings for PDGFRA presented in [Figure 1](#fig1){ref-type="fig"}B. In pre-implantation embryos, *Tbx3* expression mostly restricts to the ICM as shown by the negatively correlated TE markers (*Eomes* and *Cdx2*; [Figure S1](#mmc1){ref-type="supplementary-material"}K).

To verify TBX3 heterogeneity observed in vivo in more detail, we used a transgenic TBX3^GFP^ (TBX3-BAC-EGFP) reporter mouse, well correlating with endogenous TBX3 protein levels ([@bib27]). We avoided the TBX3-Venus system in that context to exclude the potential of a TBX3 haploinsufficiency phenotype and due to previous reports showing conflicting results for different *Nanog* knockin reporters ([@bib20], [@bib44]). Moreover, recently, a BAC-NANOG reporter was shown to be a reliable tool for tracing *Nanog* expression in mESCs ([@bib67]). Here, we isolated mESCs from the ICM of this strain to serve as a live-time TBX3 tracking tool in vitro ([Figure 1](#fig1){ref-type="fig"}C). Under LIF/feeder conditions, we observed differential GFP expression, representing a spectrum of endogenous TBX3 expression levels. In contrast, under feeder-free 2i conditions ([@bib21], [@bib48]), GFP was homogenously expressed at high levels ([Figures 1](#fig1){ref-type="fig"}C, 1D, and [S2](#mmc1){ref-type="supplementary-material"}A). Consequently, we performed FACS of LIF/feeder ESCs and isolated ESCs expressing high, mid, or low levels of TBX3^GFP^. As expected, reporter intensity reflects endogenous *Tbx3* expression ([Figures 1](#fig1){ref-type="fig"}D and 1E), further mirrored by single-cell qPCR ([Figure S2](#mmc1){ref-type="supplementary-material"}B). To investigate whether TBX3^GFP^-low or TBX3^GFP^-high ESCs can switch from one condition to the other, we sorted ESCs for respective GFP states into low- and high-expressing populations ([Figure 1](#fig1){ref-type="fig"}F). Both subpopulations regenerated bona fide ESC cultures. TBX3^GFP^-low cells generated colonies containing TBX3^GFP^-high cells and vice versa ([Figure 1](#fig1){ref-type="fig"}G). Interestingly, colony-forming efficiency was lower for single TBX3^GFP^-low ESCs compared to TBX3^GFP^-high cells. However, both gave rise to heterogeneous colonies. As expected, 2i cultures of TBX3-BAC-EGFP cells displayed highest clonal growth rates ([Figures 1](#fig1){ref-type="fig"}H and 1I).

Next, we compared transcriptional profiles of TBX3^GFP^-low and TBX3^GFP^-high mESCs (LIF/feeder) and observed a differentially regulated gene signature ([Figure S2](#mmc1){ref-type="supplementary-material"}C; [Tables S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, and [S4](#mmc5){ref-type="supplementary-material"}). Hierarchical clustering with mouse embryonic fibroblasts (MEFs) and reference ESC sets positioned TBX3-high and -low cells to the pluripotent references, excluding that TBX3-low cells simply represent differentiating ESCs ([Figure 1](#fig1){ref-type="fig"}J). PluriNet has been shown to define a common gene signature defining bona fide pluripotent cell types such as mESCs, induced pluripotent stem cells (iPSCs), and human oocytes ([@bib41], [@bib45]). Applying this signature to TBX3^GFP^-low and TBX3^GFP^-high ESCs clearly illustrates the robust pluripotent state of both cell types ([Figure 1](#fig1){ref-type="fig"}K). Interestingly, TBX3^GFP^-low cells also showed enrichment for transcripts expressed in EPI stem cells ([Figures 1](#fig1){ref-type="fig"}L \[[@bib49]\] and [S2](#mmc1){ref-type="supplementary-material"}D \[[@bib36]\]). Next, we correlated TBX3^GFP^-low and TBX3^GFP^-high cells relative to published datasets from EpiSCs and E5.5/6.5 EPIs and from ESCs and E3.5 ICM. Consistent with the above findings, TBX3^GFP^-low cells clustered closer to EPI and EpiSCs than to ESCs and vice versa, whereas TBX3^GFP^-high cells clustered closely to the ICM, similar to reference ESCs cultured under 2i conditions ([Figure 1](#fig1){ref-type="fig"}M).

Low Levels of Tbx3 Restrict Developmental Potential In Vivo {#sec2.2}
-----------------------------------------------------------

Finally, we performed embryo aggregation assays using freshly sorted LV-mCherry-labeled TBX3^GFP^-low or TBX3^GFP^-high cells and wild-type E2.5 embryos ([Figure 2](#fig2){ref-type="fig"}A). Both cell populations were capable to integrate into the ICM as observed by the constitutively expressed mCherry reporter at E3.5 ([Figures 2](#fig2){ref-type="fig"}B and 2C). 120 aggregates from each population were transferred to pseudopregnant mice for further development. Sixty-nine and 28 embryos from the TBX3^GFP^-low and TBX3^GFP^-high aggregates were recovered, of which 14 (20.3%) and 22 (78.6%) were classified to be chimeric ([Figure 2](#fig2){ref-type="fig"}D). Notably, very similar numbers of embryos implanted, although a lower number of fetuses was recovered from the TBX3^GFP^-high cell population. We hypothesize that the high contribution ability of TBX3^GFP^-high mESCs may limit the survival rate of this group as described previously ([@bib22]). Chimeric embryos recapitulated previously reported *Tbx3*-expression patterns as seen by the BAC-EGFP signal ([Figure 2](#fig2){ref-type="fig"}E; [@bib27]). Interestingly, the frequency of TBX3-low chimeric embryos was overall significantly lower ([Figure 2](#fig2){ref-type="fig"}D). Unfortunately, the LV-mCherry reporter appeared to be silenced in all embryos, impeding a more detailed characterization of chimerism. This highlights that TBX3-low ESCs have a significantly reduced potential for in vivo contribution to chimeric embryos, underpinning our in vitro observations that a TBX3-low state represents a differentiation-poised but pluripotent state.

Tbx3 Is Dispensable to Establish and Maintain Pluripotency {#sec2.3}
----------------------------------------------------------

Because the spectrum of TBX3-low and -high expression is compatible with pluripotency, we investigated genetic ablation of TBX3 in induction and maintenance of pluripotency. First, low passage TBX3^*+/+*^ and TBX3^*−/−*^ MEFs ([@bib20], [@bib34]) were assayed for reprogramming toward iPSCs. These MEFs did not show significant differences in their proliferative capacity over three passages (data not shown). Interestingly, alkaline phosphatase (AP)-positive iPSC colonies appeared in similar numbers in TBX3^*−/−*^ MEFs compared to wild-type controls ([Figures 3](#fig3){ref-type="fig"}A--3C). We also assessed colony formation kinetics by counting iPSC-like colonies without observing any difference. Using higher passages of TBX3^*−/−*^ MEFs led to fewer iPSC colonies (data not shown). This observation would be in line with previously reported data showing that CAPERα/TBX3 repressor complex is required to prevent senescence, the latter representing an established barrier for reprogramming ([@bib3], [@bib34]). Indeed, TBX3 mRNA and protein were absent in TBX3^*−/−*^ iPSC lines ([Figures 3](#fig3){ref-type="fig"}D and 3E). These colonies displayed normal dome-shaped morphology and pluripotency marker expression ([Figures 3](#fig3){ref-type="fig"}F and [S3](#mmc1){ref-type="supplementary-material"}A). Transcriptome cluster analysis of TBX3^−/−^ iPSCs further confirmed pluripotency ([Figure 3](#fig3){ref-type="fig"}G). To complement these findings, we investigated again the TBX3-Venus mouse strain (see also [Figure 1](#fig1){ref-type="fig"}A). Mating heterozygous mice with subsequent embryo isolation allowed us to culture E3.5 blastocysts for de novo ESC derivation ([@bib11]). From 24 blastocysts, 22 ESC lines were expanded, 3 TBX3^*+/+*^, 11 TBX3^*ven/+*^, 7 TBX3^*ven/ven*^, and 1 line undetermined ([Figure 3](#fig3){ref-type="fig"}H). Morphology and marker staining confirmed pluripotency, whereas the Venus reporter signal localized to the outgrowing ICM ([Figures 3](#fig3){ref-type="fig"}I, [S3](#mmc1){ref-type="supplementary-material"}B, and S3C). FACS analysis for the Venus reporter as well as mRNA and protein analysis confirmed the TBX3-null status ([Figures 3](#fig3){ref-type="fig"}J, 3K, [S3](#mmc1){ref-type="supplementary-material"}D, and S3E).

Tbx3 Is Dispensable for the Formation of "All-PSC"-Derived Mice and Germ Cell Development {#sec2.4}
-----------------------------------------------------------------------------------------

A hallmark of PSCs is the ability to form teratomas and to generate chimeric embryos upon blastocyst injection. Indeed, TBX3^*−/−*^ iPSCs generated teratomas ([Figure 3](#fig3){ref-type="fig"}L). Surprisingly, even diploid (2n) embryo aggregation of TBX3^*−/−*^ ESCs led to high-grade chimeras at E9.5 ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Moreover, both TBX3^*−/−*^ ESCs and iPSCs were capable of generating all-PSC-derived embryos ([Figures 3](#fig3){ref-type="fig"}M and [S4](#mmc1){ref-type="supplementary-material"}A) in tetraploid (4n) embryo aggregation, the most stringent test for pluripotency ([@bib56]). In line with the previously reported TBX3^*−/−*^ phenotype ([@bib20]), all-PSC embryos (∼85%) were found developmentally arrested and dead at E11.5 ([Figure S4](#mmc1){ref-type="supplementary-material"}B; [Table 1](#tbl1){ref-type="table"}).

To assess germline contribution of TBX3^*−/−*^ PSCs, we introduced an OCT4-EGFP reporter into tdTomato-labeled TBX3^*−/−*^ iPSCs ([Figure S4](#mmc1){ref-type="supplementary-material"}C). In a 2n aggregation assay, high germline contribution of TBX3^*−/−*^ cells in five out of 12 E12.5 chimeric fetuses (presence of OCT4-EGFP-positive cells in gonads) indicated that TBX3 is not required for germ cell development ([Figure 3](#fig3){ref-type="fig"}N). Large clusters of OCT4-EGFP-positive spermatogonia stem cells (SSCs) were observed in the seminiferous tubules of a newborn mouse chimera ([Figure 3](#fig3){ref-type="fig"}O). However, the seminiferous tubules of an adult chimeric mouse showed very few and small clusters of OCT4-EGFP-positive cells, despite the presence of large amounts of tdTomato-positive TBX3^*−/−*^*-*iPSC-derived cells ([Figures 3](#fig3){ref-type="fig"}P and 3Q). Spermatozoa from this mouse were used for in vitro fertilization (IVF) with oocytes from B6C3F1 mice, but no germline transmission could be achieved in 44 developed blastocysts as judged by tdTomato and OCT4-EGFP fluorescence. In addition, a chimeric TBX3-null mouse gave rise to four litters with 54 F1 pups in total and none of them was RFP positive in the somatic part or OCT4-EGFP positive in gonads. We conclude that, although TBX3 is not required for germ cell development, it seems to be essential for the maintenance of SSCs after birth.

TBX3 Removal from the Pluripotency Circuitry Delays Lineage Commitment {#sec2.5}
----------------------------------------------------------------------

Next, we investigated the cell-cycle profile of TBX3^*−/−*^ ESCs using two complementary methods without observing significant differences compared to controls ([Figures 4](#fig4){ref-type="fig"}A and 4B; data not shown). Also, there was no difference in single-cell colony formation capacity in TBX3 wild-type versus null ESCs, irrespective of removal of any LIF/2i component. This indicates that LIF/STAT3, ERK, and GSK3 signaling is unperturbed in TBX3^*−/−*^ cells ([Figure 4](#fig4){ref-type="fig"}C). Interestingly, TBX3^*−/−*^ cells outperformed their wild-type counterparts in a cell competition assay, indicating enhanced self-renewal in TBX3^*−/−*^ ESCs ([Figures 4](#fig4){ref-type="fig"}D and 4E). It has been shown that reducing OCT4 levels directs an even more robust pluripotent state ([@bib31]). On a global gene expression level, only TBX3^*−/−*^ iPSCs, but not ESCs, display greater enrichment of the PluriNet signature (data not shown).

To test the differentiation capacity of TBX3^*−/−*^ ESCs in vitro, we removed LIF/2i in a serum-based medium to allow spontaneous differentiation. TBX3^*−/−*^ ESCs displayed a delay in losing typical ESC morphology compared to controls ([Figures 4](#fig4){ref-type="fig"}F and [S5](#mmc1){ref-type="supplementary-material"}). Of note, TBX3^*−/−*^ ESCs showed higher mRNA baseline levels of *Oct4*, *Sox2*, and *Nanog* ([Figures 4](#fig4){ref-type="fig"}G and 4H). Downregulation of pluripotency markers assimilated rapidly, whereas upregulation of the endodermal differentiation markers was limited in TBX3-null cells. In contrast, *brachyury* (*T*) upregulation occurred earlier in TBX3^*−/−*^ cells in line with a recent study ([@bib63]; [Figures 4](#fig4){ref-type="fig"}H and 4I). This supports previous observations showing that TBX3 fine-tunes early cell fate choices in a dose-dependent manner ([@bib30], [@bib40], [@bib64]).

Loss of Tbx3 Leads to Complex Compensational Processes {#sec2.6}
------------------------------------------------------

Previously, a simplified pluripotency circuitry was described ([@bib17]). We combined this network with TBX3-ChIP-sequencing data ([@bib24]) and our gene expression data of wild-type versus TBX3^*−/−*^ ESCs cultured under LIF/2i conditions to obtain a more global view on the molecular changes upon TBX3 removal. [Figure 5](#fig5){ref-type="fig"}A shows a network in which the inner circle describes core factors of pluripotency, whereas the outer circle depicts TBX3-bound genes that are differentially regulated in TBX3^*−/−*^ ESCs. Most pluripotency markers in the inner circle did not show significant changes in their gene expression, although *Klf4/5*, *Esrrb*, *Tfcp2l1*, and *NrOb1* were slightly downregulated in TBX3^*−/−*^ ESCs compared to controls (yellow/red color in [Figure 5](#fig5){ref-type="fig"}A) and qPCR indicated upregulation of *Oct4*, *Sox2*, and *Nanog* ([Figures 4](#fig4){ref-type="fig"}G and 4H). TBX3 is a transcriptional repressor ([@bib2]). We hypothesize that loss of TBX3 may lead to an upregulation of specific genes impacting on pluripotency that are usually repressed by TBX3. TBX3-bound genes in the outer circle showed that *Dppa3*, *Fzd2*, *Abcc2*, *Alk*, and *Dnmt3a* transcripts were significantly increased in TBX3^*−/−*^ ESCs ([Figure 5](#fig5){ref-type="fig"}A). To narrow down this list, we compared the upregulated genes in TBX3^*−/−*^ ESCs with the TBX3 target genes identified by a *Tbx3* knockdown experiment ([@bib24], [@bib47]), resulting in an overlap of 20 candidate genes ([Figures 5](#fig5){ref-type="fig"}B and 5C). The sole overlapping candidate between this approach and our network was *Dppa3/Stella*, a gene described to impact on pluripotency and germ cell development ([@bib26], [@bib51], [@bib63], [@bib68]). Our microarray data and single-cell qPCR confirmed the reciprocal relationship between *Tbx3* and *Dppa3* ([Figures 5](#fig5){ref-type="fig"}D, 5E, and 5G). Additionally, the DPPA3 promoter is occupied by TBX3 and possesses bivalent modifications as expected for genes regulating pluripotency ([Figure 5](#fig5){ref-type="fig"}F). Unexpectedly, the knockdown of *Dppa3* in TBX3^*−/−*^ iPSCs did not impact on pluripotency as shown by colony formation assays and qPCR ([Figures 5](#fig5){ref-type="fig"}G--5I). We conclude that compensational mechanisms allow a TBX3^*−/−*^ state independent of DPPA3 and most likely involve a complex compensational network, not only involving direct (as suggested by [Figure 5](#fig5){ref-type="fig"}A) but also indirect TBX3 target genes. Still, it appears rather antithetic that downregulation of TBX3 inversely correlates with developmental potential, whereas complete loss of TBX3 leads to overcompensation and a reduced propensity to differentiate. To address this point, we looked for overlap among the differentially regulated genes in TBX3-low and -high and TBX3^*−/−*^ and wild-type ESCs. Due to the developmental differences of these cell states, only a limited number of genes were commonly regulated ([Figure 5](#fig5){ref-type="fig"}J; [Tables S5](#mmc6){ref-type="supplementary-material"}, [S6](#mmc7){ref-type="supplementary-material"}, [S7](#mmc8){ref-type="supplementary-material"}, and [S8](#mmc9){ref-type="supplementary-material"}). Interestingly, a gene set associated with "DNA methylation" was enriched only in TBX3^*−/−*^ cells and not in TBX3-low cells, indicating global epigenetic differences, particularly in TBX3^*−/−*^ cells ([Figures 5](#fig5){ref-type="fig"}K and 5L).

Discussion {#sec3}
==========

A series of studies has reported that TBX3 was indispensable for maintenance of pluripotency. In line, TBX3 gain of function facilitated induction of pluripotency ([@bib24], [@bib28], [@bib37], [@bib40], [@bib47]) but interestingly also lineage commitment ([@bib30], [@bib40], [@bib64]). In line with a recent study ([@bib63]), we provide clear evidence that TBX3 is absolutely dispensable for both maintenance and induction of pluripotency. Additionally, we show that its removal alters pluripotency exit. In a wild-type context, TBX3 is heterogeneously expressed in the developing embryo in vivo but also in ESCs in vitro and various TBX3 expression levels correlate with distinct developmental potential.

Heterogeneous expression of pluripotency factors has been described and studied in detail for Nanog when cultured under LIF/FCS conditions. Single-cell resolution confirmed this observation and correlates a TF-low state with a more committed EPI-like state ([@bib46], [@bib50], [@bib58]). The advent of serum-free LIF/2i cultures, which virtually erases TF heterogeneity, questions this observation as a relic of outdated culture conditions, whereas others envision it as a stochastic advantage mimicking the dynamic fluctuations in the developing embryo ([@bib43], [@bib61]). Though heterogeneity in vivo is established as early as in the four- to eight-cell stage (e.g., NANOG), reciprocal lineage patterning between NANOG/CDX2 occurs later ([@bib14]). These lineage segregation events have been defined into at least three rapid but sequential events in vivo ([@bib55]), whereas mESCs cultured under LIF/2i conditions are arguably more similar to the EPI cells found in diapause embryos ([@bib1], [@bib46], [@bib50], [@bib58]). Therefore, heterogeneity found in mESCs cultured in LIF/FCS might be a closer reflection of the heterogeneity found in vivo in pre-implantation blastocysts. Notably, neither culture regime precisely recapitulates the in vivo situation ([@bib42]). In turn, most likely each cell culture system presents distinct advantages to study various facets of pluripotency and lineage commitment.

We complemented such in vitro observations with in vivo assays that allow to rigorously test the pluripotent potential of defined cell populations. In the context of wild-type mESCs, expression of *Tbx3* inversely correlates with the capacity to form chimeric embryos and thereby supports the hypothesis that TBX3-low cells resemble committed EPI-like cells ([@bib50]). Moreover, we show that, even after cross-platform adjustment, the transcriptome of our TBX3-high cells converges on that of the ICM, whereas TBX3-low cells better resemble the E5.5/6.5 EPI.

Our data identify dynamic fluctuations in TBX3-expression levels to be linked with developmental potency of PSCs and hint that, within the heterogeneous TBX3 expression found in the late blastocyst, TBX3-high correlates with a Nanog-low state and thus PE cell fate specification ([@bib48], [@bib67]). This was independently confirmed by re-analyzing RNA sequencing data of single embryonic cells in pre-implantation embryos. Interestingly, a recent report described occasional transitions in NANOG expression in vivo from the PE back to the EPI ([@bib67]). It would be of interest in the future to perform live-time imaging studies to track the fate of various TBX3 states to their progeny in pre- and postimplantation embryonic stages.

We were able to generate TBX3-null PSCs showing all hallmarks of pluripotency. This strongly contradicts several previous reports ([@bib24], [@bib28], [@bib37], [@bib40], [@bib47]) but supports a very recent study ([@bib63]). Additionally, it seems to be in conflict with our findings that TBX3-low cells represent a differentiation-poised late EPI state. A series of reports revealed strong variability between different EPI lines with various degrees of lineage bias and developmental potential ([@bib5], [@bib25], [@bib46], [@bib58]). Nevertheless, germline transmission or even the generation of all-PSC mice upon 4n embryo aggregation has never been reported for EpiSCs ([@bib5], [@bib25]). Intriguingly, recent studies implicated that the pluripotency circuitry can be perturbed in both directions, either toward differentiation or to a pluripotency arrested state with a hampered differentiation capacity as shown for the reduction of OCT4 expression ([@bib31], [@bib53]). We observe similar behaviors in TBX3-null cells. These cells not only keep their undifferentiated state longer than wild-type counterparts upon LIF/2i removal but also outperform wild-type cells in a competition assay. They also successfully formed all-PSC-derived mouse embryos in a 4n assay displaying the reported TBX3-null phenotypes ([@bib12], [@bib20]).

Previous studies identified TBX3 as an important driver and enhancer for iPSC formation ([@bib24]). In our hands, reprogramming of TBX3-null MEFs occurred with similar efficiencies and kinetics compared to wild-type MEFs. Expanded clones retain the full ground state pluripotency. Interestingly, normal germline development occurred in TBX3-null mice, although it seems to be essential for the maintenance of SSCs after birth based on our observation using *IVF* with sperm from a TBX3-null iPSC chimeric mouse. The TBX2 subfamily (TBX2, 3, 4, and 5) has been previously implicated in the development of the reproductive system ([@bib15]), and overexpressing TBX3 with the Yamanaka factors generated iPSCs with higher capacity for germline contribution ([@bib24]). TBX3 is only expressed in genital ducts, and deletion of TBX4, a close family member of TBX3 ([@bib6]), led to a reduced amount of primordial germ cells but with subsequent normal fertility ([@bib16]). Further studies need to clarify the precise role of TBX3 for germ cell development, particularly in light of the intimate connection between DPPA3/STELLA and TBX3 ([@bib16], [@bib63]). Thus, TBX3 supports but is not absolutely required to maintain and install pluripotency and germ cell development, probably due to an alternate pluripotency network. Transcriptome analysis and downstream bioinformatical analysis of TBX3-null PSCs helped to identify putative compensators revealing DPPA3 as the most promising candidate, in line with a recent study ([@bib63]). Although we confirmed an intimate connection between TBX3 and DPPA3, self-renewal of TBX3-null cells remained stable upon depletion of DPPA3. Most likely several lines of compensation may allow ongoing self-renewal in TBX3-null cells. In fact, [@bib63] also observed just partial compensation by DPPA3 in the TBX3-null state. Most likely, differences in the genetic background or distinct cell culture conditions further impact the observed differences between our study and Waghray et al. Nevertheless, the intimate connection between TBX3 and DPPA3 remains and needs to be explored in detail in future studies.

Our observations of an enriched DNA-methylation signature only in TBX3-null and not in the TBX3-low cells indicate additional epigenetic mechanisms that may be implicated and warrant further investigation ([Figure 5](#fig5){ref-type="fig"}L). Notably, DPPA3 and DNMT3a were found to be associated during cellular reprogramming and DNA methyltransferases are critical for both genome integrity and differentiation capacity of mESCs ([@bib4], [@bib68]). Moreover, OCT4 haploinsufficiency stabilizes the pluripotency circuitry not only at the transcriptional level but also at the epigenetic level via higher occupancy of key regulatory elements supporting pluripotency ([@bib31], [@bib53]). Taken together, we have deciphered further aspects of TBX3 activity within the pluripotency circuitry and identify variable pluripotency states, which underpin the dual role of pluripotency for both indefinite self-renewal and cell lineage specification.

Experimental Procedures {#sec4}
=======================

Full methods accompany this paper.

Ethics Statement {#sec4.1}
----------------

All animal experiments were performed in compliance with the guidelines for the welfare of experimental animals issued by the Federal Government of Germany, the NIH, and the Max Planck Society. The experiments in this study were approved by the review board of the Land Baden-Wuerttemberg and the ethics committee of Ulm University.

Reprogramming and PSC Culture {#sec4.2}
-----------------------------

MEFs were isolated and reprogrammed according to standard protocols from TBX3^+/−^ and TBX3^*−/−*^ mice ([@bib32]).

Isolation of mESCs from Blastocysts {#sec4.3}
-----------------------------------

TBX3-BAC-EGFP mESCs and TBX3-KI-Venus mESCs were derived using previously reported methods by breeding TBX3-BAC-EGFP and TBX3-KI-Venus heterozygous mice, respectively ([@bib8]).

Western Blot {#sec4.4}
------------

Western blotting was performed according to standard procedures ([@bib39]). Whole-cell extracts (50--100 μg) prepared using RIPA lysis buffer containing 50 mM Tris HCl (pH 8.0), 150 mM NaCl, 0.05% Na-Deoxycholat, 1% NP40, 0.01% SDS, and 1 mM PMSF supplemented with Complete Protease Inhibitor Cocktail Tablets (Roche) were subjected to SDS-PAGE.

IHC {#sec4.5}
---

IHC was performed as described in [@bib54] and [@bib57]. Cells at different time points of differentiation were fixed using 4% paraformaldehyde (PFA). Nuclei were stained with DAPI. Images were captured using an upright fluorescence Zeiss Axioimager Z1 microscope and analyzed using Axiovision software (Zeiss).

Microarray Data Analysis {#sec4.6}
------------------------

The DNA microarray data were pre-processed and normalized by the limma package ([@bib65]). The differentially expressed genes of a pairwise comparison were detected using limma t test with criteria of fold change \>2 and p value \< 0.05. The p value was further adjusted by the procedure of Benjamini and Hochberg ([@bib33]).
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![TBX3 Is Dynamically Expressed in Mouse ESCs\
(A) TBX3^+/ven^ pre-implantation embryos at indicated time points.\
(B) Wild-type pre-implantation embryos stained for NANOG (green), TBX3 (red), and PDGFRa (purple). Hoechst 33342 is shown (nuclei, blue).\
(C) Representative phase contrast and GFP fluorescent images of de-novo-derived TBX3-BAC-EGFP mESCs cultured under indicated conditions. The scale bars represent 20 μm.\
(D) TBX3-BAC-EGFP expression fluctuates under indicated culture conditions.\
(E) qPCR for *Tbx3* of TBX3-BAC-EGFP low, mid, and high sorted cells (according to D). n = 4; two individual clones from two independent experiments)\
(F and G) Experimental sorting strategy and schematic results (F) of (G); n = 2, two independent clones.\
(H and I) Sorting strategy and schematic results (H) of (I). Two out of four independent experiments with similar results are shown. For 2i condition, n = 2.\
(J) Hierarchical clustering of gene expression profiles of TBX3^GFP^-high and -low ESCs with published pluripotent and somatic cells ([GSE11274](ncbi-geo:GSE11274){#intref8020} and [GSE58735](ncbi-geo:GSE58735){#intref0020}).\
(K and L) Gene set enrichment analysis shows no bias of pluripotent marker genes between TBX3^GFP^-high (high) and -low (low) ESCs (J) but a bias to epiblast (K) in TBX3^GFP^-low ESCs.\
(M) Hierarchical clustering shows that TBX3^GFP^-low ESCs (TBX3 low) cluster close to EpiSCs and epiblast (E5.5/6.5), TBX3^GFP^-high ESCs (TBX3 high) are close to published ESCs (J1, R1), 2i-treated ESCs (J1_2i), and E3.5 inner cell mass (ICM cells E3.5; [GSE58735](ncbi-geo:GSE58735){#intref0025} and [GSE35416](ncbi-geo:GSE35416){#intref6025}).\
See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Low Levels of Tbx3 Restrict Developmental Potential In Vivo\
(A) Scheme of sorting strategy and 2n aggregation assay with E2.5 embryos.\
(B and C) Generation of chimeric embryos by aggregating TBX3-BAC-EGFP high/low ESCs infected with LvCherry lentivirus with 2n E2.5 embryos (B) and ESCs integrated into ICM of chimeric blastocysts after 24 hr in culture (E3.5). (C) Top, phase contrast; middle, LvCherry signal for lentiviral labeling of cells to ensure visualization; bottom, GFP signal of the TBX3-BAC-EGFP high and low ESCs.\
(D) Embryonic development from 2n embryo aggregation with TBX3^GFP^-high and -low ESCs.\
(E) Phase contrast (left) and GFP fluorescence (right) of TBX3-BAC-EGFP-low chimera. fl, front limb; hl, hind limb; m, midbrain.\
The scale bars represent 50 μm (B and C) and 1 mm (E).](gr2){#fig2}

![Tbx3 Is Dispensable to Induce and Maintain Pluripotency\
(A and B) Quantification (A) and representative AP+ colonies (B) day 12 after reprogramming of TBX3^+/+^ and TBX3^−/−^ MEFs. Three independent experiments performed with triplicate technical replicates are shown.\
(C) Morphology of OKS-infected TBX3^−/−^ MEFs (top) picked and expanded TBX3^−/−^ iPSCs (bottom).\
(D) *Tbx3* expression in TBX3^+/−^ and (TBX3^−/−^) iPSCs. Two independent experiments performed with triplicate technical replicates are shown.\
(E) TBX3 western blot in iPSCs (two different antibodies). Representative images of at least three independent experiments are shown.\
(F) Pluripotency marker IHC in generated iPSCs of the indicated genotypes.\
(G) Hierarchical clustering of gene expression profiles shows that iPSCs cluster with published ESC/ICM datasets.\
(H) Crossing scheme to obtain TBX3^ven/ven^-null mice and overview of derivation frequency; ND, not determined.\
(I) Pluripotency marker IHC in de novo ESCs of the indicated genotypes.\
(J and K) TBX3 mRNA (J; three independent experiments performed with triplicate technical replicates) and protein (K) expression confirms TBX3-null phenotype in TBX3^ven/ven^ ESCs (two TBX3 antibodies). Representative images of at least three independent experiments are shown.\
(L) TBX3^−/−^ iPSCs form teratomas with all three germ layers (ecto-, meso-, and endoderm) in NMRI mice.\
(M) Generation of "all-PSC"-derived TBX3-null embryos using 4n embryo aggregation from TBX3^−/−^ iPSCs. Developmental stage as indicated. To ensure visualization of TBX3-null progeny, TBX3^−/−^ iPSCs were constitutively labeled with a tdTomato-expressing lentivirus (LVtdTomato).\
(N) Germline contribution of TBX3^−/−^ iPSCs carrying an OCT4-EGFP reporter and LVtdTomato after 2n aggregation assay in female (left) and male (right) gonads at E12.5.\
(O) Representative fluorescent image of newborn chimeric mouse testis after 2n aggregation assay of OCT4-EGFP and LVtdTomato-infected TBX3^−/−^ iPSCs.\
(P) TBX3^−/−^ iPSCs contribute to adult chimeric mice after 2n aggregation assay (light coat color).\
(Q) Representative fluorescent image of adult chimeric mouse testis after 2n aggregation assay of OCT4-EGFP and LVtdTomato-infected TBX3^−/−^ iPSCs.\
The scale bars represent 50 μm. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Characterization of TBX3-Null ESCs\
(A) BrdU-FACS of TBX3^ven/ven^ and TBX3^+/+^ ESC lines. Gate at y axis, apoptotic cells; lower left circle, G0/G1 population; lower right circle, G2/M population; upper big gate, S phase.\
(B) Quantification of BrdU incorporation summarized from three TBX3^ven/ven^ and a TBX3^+/+^ ESC line. n = 3 (three individual clones). DAPI-based cell-cycle analysis revealed no difference between TBX3^ven/ven^ and TBX3^+/+^ ESCs (data not shown).\
(C) Quantified AP+ colonies after removing individual LIF/2i components. N2B27 backbone medium. n = 3, for two independent clones with duplicate technical replicates.\
(D) Co-culture strategy to compare self-renewal capacity of TBX3^+/+^ and TBX3^ven/ven^ mESC under LIF/2i. Analysis at start (P0) and end of experiment (P3) for venus expression via FACS is shown. n = 3, for two independent clones with duplicate technical replicates.\
(E) Quantification of cell populations from (D) after three passages.\
(F) Phase images of TBX3^ven/ven^ and TBX3^+/+^ mESC at 0 hr, 24 hr, 48 hr, and 72 hr after withdrawal of LIF and 2i. Delayed differentiation of TBX3^ven/ven^ as evident by preserved ESC morphology. The scale bars represent 20 μm.\
(G--I) mRNA levels of pluripotency markers (*Oct3/4*, *Sox2*, and *Nanog*), early endodermal markers (*Foxa2*, *Eomes*, and *Hnf4a*), *T* (*brachyury*) mesodermal, and *Pax6* as ectodermal marker in TBX3^+/+^ and TBX3^ven/ven^ mESC at respective time points of LIF/2i withdrawal. Two clones per genotype are shown.\
Two independent experiments performed with triplicate technical replicates are shown. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![TBX3 Depletion Leads to Complex Compensational Processes\
(A) Molecular circuitry of pluripotency markers (inner layer) and TBX3 target genes (outer layer) generated by the STRING database. The color of a node reflects the change in gene expression level between wild-type (WT) and TBX3-null (KO) ESCs. Black edge shows an evident interaction (confidence score \> 0.7) between two connected genes from the STRING database. The gray edge connects TBX3 with its target genes identified by ChIP-seq data ([GSE19219](ncbi-geo:GSE19219){#intref0110}; [@bib24]).\
(B) Venn diagram of upregulated genes in TBX3-null ESCs and *Tbx3* knockdown ESCs ([GSE26520](ncbi-geo:GSE26520){#intref0210}), compared to respective wild-type controls, shows 20 candidate genes.\
(C) Heatmap of gene expression level of these candidate genes. Light green, below median expression; dark green, above median.\
(D) The expression level of *Dppa3* in TBX3^+/+^and TBX3^−/−^ iPSCs, wild-type (+/+), and TBX3-null (ven/ven) ESCs.\
(E) Clustering of single-cell *Dppa3* expression (n = 26) suggests the reciprocal expression between *Tbx3* and *Dppa3* (hypergeometric test; p = 0.023). Dark green, group of low *Dppa3* expression; light green, group of high *Dppa3* expression. TBX3-low-sorted single cell is shown (GFP-L no. X). TBX3-high-sorted single cell is shown (GFP-H no. X).\
(F) TBX3 occupancy ([GSE19219](ncbi-geo:GSE19219){#intref0310}) and H3K4me3/H3K27me3 bivalent modifications ([GSE31039](ncbi-geo:GSE31039){#intref0410}) of DPPA3 promoter region in ESCs.\
(G) Dppa3 expression in WT or TBX3^−/−^ iPSCs upon transduction with scramble control virus or various combinations of different shRNAs targeting Dppa3. Two independent experiments performed with triplicate technical replicates are shown.\
(H) Colony formation of TBX3^−/−^ iPSC lines with shRNAs against *Dppa3* upon clonal density seeding. Top, representative AP-stained plates; bottom, quantification of three independent experiments performed with triplicate technical replicates. Black bar, AP positive; grey bar, partially AP positive; light gray bar, AP negative.\
(I) qPCR of pluripotency markers in *Dppa3* knockdown and scramble control TBX3^−/−^ iPSC lines (three independent experiments performed with duplicate technical replicates).\
(J) Comparisons of differentially regulated genes between TBX3-high and -low ESC and between TBX3 WT (+/+) and TBX3-null (ven/ven) ESCs.\
(K and L) The GO terms of DNA methylation (GO0006306) show no bias toward TBX3-high or -low ESCs (K) but were significantly enriched in TBX3-null ESCs (L).](gr5){#fig5}

###### 

Quantitative Overview of 2n and 4n Embryo Aggregation of the Indicated Cell and Genotypes

  Cell Type                           Approach   Aggregation   Transferred   E9.5   E11.5   GFP Positive       
  ----------------------------------- ---------- ------------- ------------- ------ ------- -------------- --- ----
  iPSC TBX3^Δflox/Δflox^              4n         50            47            −      −       41             6   −
  iPSC TBX3^Δflox/Δflox^+ tdTomato    4n         50            46            12     10      29             6   −
  iPSC TBX3^Δflox/Δflox^ + tdTomato   4n         40            40            20     8       −              −   −
  iPSC TBX3^Δflox/Δflox^ + tdTomato   2n         47            47            35     22      −              −   −
  ESC TBX3^ven/ven^ Clone 4a          4n         20            20            19     14      −              −   −
  ESC TBX3^ven/ven^ Clone 4a          2n         27            27            21     15      −              −   −
  ESC TBX3^+/+^ Clone 21              4n         20            20            10     8       −              −   −
  ESC TBX3^+/+^ Clone 21              2n         18            17            8      6       −              −   −
  ESC TBX3^ven/ven^ Clone 5 + GFP     4n         54            53            40     8       −              −   8
  ESC TBX3^ven/ven^ Clone 5 + GFP     2n         48            48            41     24      −              −   13
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